CTRL Therapeutics
Chicago, United States · Founded 2023
- Headquarters
- Chicago, Illinois
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- ctrl-therapeutics.com
- Last Round
- Series ASep 2024
- Rounds
- 2
About
CTRL Therapeutics is developing a first-of-its-kind polyclonal cell therapy platform to treat solid tumors using circulating tumor-reactive lymphocytes (cTRLs) isolated from blood rather than tumor tissue. The company's proprietary IsoQore™ cell-sorting platform enables efficient extraction of millions of cTRLs through a simple blood draw, avoiding invasive surgical procedures required by traditional TIL therapies. CTRL's lead product, cTRL-001, aims to provide a scalable, outpatient-ready solution for a broad range of solid tumors.
Summary
CTRL Therapeutics is a Life Sciences company based in Chicago, United States, founded in 2023. Its most recent funding was a Series A round in Sep 2024. Investors include General Catalyst, Portal Innovations and Intermountain Healthcare.
Funding History
Sep 2024
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ctrl-therapeutics"><img src="https://indexed.vc/api/badge/company/ctrl-therapeutics" alt="CTRL Therapeutics on Indexed.vc" width="260" height="76" /></a>